Key facts
- Translucent AI’s last known valuation is $110.0M (Mar 2026).
- It has raised $34.0M; the latest was Early Stage VC ($27.0M) in Mar 2026.
- Notable investors include GV, New Enterprise Associates, FPV Ventures, Virtue (Austin), Nea — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Translucent AI
- ·The full record, as it builds
Funding rounds
No funding rounds for Translucent AI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Translucent AI
Developer of an agentic financial analysis platform designed to provide financial planning support to healthcare operators. The company's software offers a personal analyst for financial questions, drafts analysis reports and forecasts from service-line data, allows progress monitoring, enabling healthcare teams to simplify complex workflows, reduce time needed for manual report building, identify revenue and cost improvement opportunities, and understand what drives their financial performance.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2024
- Employees
- 27
- Website
- translucent.ai/
- Ownership
- Privately Held (backing)
Translucent AI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Translucent AI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Translucent AI in its N-PORT filings yet. We sweep new filings monthly.